Insights
From stratospheric antennas to implantable bio-sensors, from the thermodynamics of carbon capture to quantum technology and AI-designed biology, we use deep tech to challenge and change the status quo.
Read our latest research and insights to help you see beyond the innovation hype and find out how emerging technologies are solving important business problems.
CC and The Engine venture ecosystem: an alignment of ambition
We're ramping up our commitment to The Engine, the ambitious venture ecosystem spun out of MIT to support ‘Tough Tech’ companies and solve key challenges in climate change, human health and advanced systems ...
A breakthrough in advanced optical sensing
The ability to count and track individual units of light can have an exciting range of applications across medtech and beyond, as a recent collaboration with Cambridge University has proved ...
Why the world needs digitally connected active implant innovation
Dr Ashwini Sharan and Cambridge Consultants provoked debate with a film, ‘A day in the life of a Parkinson’s patient in 2030’, which imagined seamless therapy enabled by smart active implants, surgical robotics, digital connectivity and AI ...
Should robots control accuracy and precision in surgery?
Should we be designing systems that autonomously control both accuracy and precision for the best outcome of the patient? Andy Savarese explores the questions and looks ahead as the role of surgical robotics evolves ...
Revolutionising health monitoring could just be the start for photonics
Photonics promises to revolutionise health monitoring. Here, Tom Watson explores the wider potential in personalised medicine – and provides insight into overcoming the key challenges that lie ahead ...
In vitro diagnostics needs seismic change
The current state of in vitro diagnostics (IVDs) is no longer fit for purpose. In vitro diagnostics needs seismic change to improve patient outcomes and deliver economic benefits ...
Getting the right distributed data architecture for you
To decentralise, or not to decentralise, that is the question. This Web3 dilemma reflects the likely thoughts of current digital leaders who want to make the best use of their digital assets while maintaining trust in their data systems ...
Can cell therapy become cheaper and easier?
Cell and gene therapy is hailed as the future of 21st century medicine but is currently too expensive to be widely used. As a principal scientist in synthetic biology, Matthew Jones is part of a team addressing this issue in ...
Real-time contamination detection for cell therapy manufacture
This whitepaper goes behind the scenes of a significant breakthrough for contamination detection in cell therapy monitoring. It tells the story of PureSentry, a prototype device for on-line, real-time detection ...
